35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Existing therapies for bipolar depression have a considerable lag of onset of action. Pharmacological strategies that produce rapid antidepressant effects-for instance, within a few hours or days-would have an enormous impact on patient care and public health.

          Related collections

          Author and article information

          Journal
          Arch Gen Psychiatry
          Archives of general psychiatry
          American Medical Association (AMA)
          1538-3636
          0003-990X
          Aug 2010
          : 67
          : 8
          Affiliations
          [1 ] Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
          Article
          67/8/793 NIHMS256272
          10.1001/archgenpsychiatry.2010.90
          3000408
          20679587
          e57a29a0-1dde-4dcf-814e-d5c2843a5f4b
          History

          Comments

          Comment on this article